The MIT spinout formerly known as Baseload Renewables hopes its lithium-sulphur battery could offer a sustainable energy source.

A round up of all the latest news on www.globaluniversityventuring.com for our subscribers.

Quentis, an immuno-oncology therapy developer based on research at Weill Cornell Medicine, has closed a round that included Taiho Pharmaceuticals and AbbVie Ventures.

Partly based on Keio University research, CureApp has developed mobile apps to help treat nicotine addiction and fatty liver inflammation.

The Global University Venturing deal net rounds up all the latest smaller deals and tracks emerging companies accessing university funds.

The business school hopes the partnership will strengthen the ecosystem, leveraging its faculty, program participants and alumni network for the initiative.